Menu & Search
           1904556600
Speak to our friendly team
Contact Us Now

New research funded by Breast Cancer Now and Cancer Research UK has found that a new blood test can detect breast cancer tumour DNA. This could enable personalised care for women with advanced breast cancer

The test can detect and monitor changes in 13 different genes. One gene that can be examined is called HER2. This gene plays a part in the development of up to 25 per cent of breast cancer cases.

If a HER2 breast cancer is detected, doctors know that this cancer can be treated with the drug Herceptin.

Dr David Guttery, from the University of Leicester, is positive about the findings of the research: “By analysing blood plasma to measure for cancer-specific changes to key breast cancer genes – including the HER2 and oestrogen receptor genes – we hope this test could help doctors and patients choose the best treatment at the best time,

According to the charity Macmillan, breast cancer is the most common type of cancer in the UK and 10 per cent of women have stage four breast cancer when they are diagnosed. The average survival rate at this stage is two years.

Baroness Delyth Morgan, chief executive of Breast Cancer Now, told the Press Association: “If validated by further research, this blood test could help tell us how a patient’s secondary breast cancer is evolving. 

“Analysing the genetic make-up of tumours could enable us to identify women who might benefit from changing their treatment, ensuring that breast cancer patients receive the most personalised therapy possible.”

The study was published in the Clinical Chemistry journal, looked at cells grown in a laboratory before they analysed the DNA from blood donated by women with advanced breast cancer.

“This study represents proof of concept, and further validation is now needed to confirm the clinical usefulness of this test before any test could be rolled out,” continued Dr Guttery.

Dr Justine Alford, senior science information officer at Cancer Research UK, said: “While survival for women with early breast cancer has greatly improved, the outlook for patients with advanced disease is still poor, something we urgently need to change. This early research could help achieve this”.

There is currently no information on when the “liquid biopsies” will be available to all patients.

Start Your Claim Today1904556600
Tell us about your case

Just send us a little bit about yourself and your claim and we will respond within 24 hours.

    Get In Touch
    Latest News

    Victims can still sue Ian Paterson

    Ian Patterson jailed In 2017, breast Surgeon, Ian Paterson was jailed for wounding with intent. He had treated thousands of patients in his 14-year […]

    Read More

    Updates to the Civil Procedure Rules – April 2021

    Updates to the Civil Procedure Rules will come into effect on 6 April 2021. In this article, Jonathan Gray highlights some of the key […]

    Read More

    Vulnerable Parties and Witnesses – CPR Update April 2021

    On 6 April 2021 an update to the Civil Procedure Rules will help vulnerable parties and witnesses to navigate litigation. The new rules acknowledge […]

    Read More

    Take a look back through our complete news archive

    Follow us on Twitter

    Being injured by a defective medical product is rare, making it all the more difficult to know what you need to do.

    One of our specialist solicitors Tamlin Bolton, has prepared a guide in case you ever find yourself in this unfortunate position.

    https://bit.ly/2qP3fBr

    Return to crowded A&Es and long ambulance delays will put patients at risk, warn experts https://www.independent.co.uk/news/health/nhs-emergency-hospital-ambulance-delays-b1830061.html?utm_content=Echobox&utm_medium=Social&utm_source=Twitter#Echobox=1618266495

    Load More...